Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TALEM: TACE, Lenvatinib, and MWA in Large HCC
NCT05555316Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2019
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
lenvatinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05555316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05555316.